United States: Patent

Subscribe
Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.
Article
IPR And PGR Statistics For Final Written Decisions Issued In June And July 2026
The Patent Trial and Appeal Board cancelled over half of instituted claims across IPR and PGR Final Written Decisions from June to July 2026, with significant variation in outcomes across different technology centers. This analysis examines claim survival rates, motion to amend statistics, and per-case disposition patterns compared to cumulative historical averages.
United States IP
FH
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Article
Federal Circuit Patent Watch: Patent Not Enabled Where Specification "Disclosed No Actual Dosages For Any Compound Within The Scope Of The Claims"
This comprehensive review examines six precedential Federal Circuit opinions from July 2026, covering critical issues in patent law including enablement requirements for pharmaceutical dosing claims, means-plus-function claim construction, anticipation defenses, and preliminary injunction standards. The cases address fundamental questions about claim scope, infringement analysis, and the evidentiary burdens required to establish patent validity and infringement in complex technical disputes.
United States IP
W
WilmerHale
Video
The Patent Enforcement Economy Is Leaving Inventors Behind/ IPWatchdog Unleashed (Video)
The patent system promises inventors exclusive rights in exchange for public disclosure, but enforcement has become prohibitively expensive, creating a minimum damages threshold that effectively rations access to justice. Litigation finance and contingency arrangements have emerged not as exploitation but as necessary responses to a system where defending patent rights can cost $12-20 million, making infringement economically rational even when patents are strong.
United States IP
LA
Licks Attorneys
Article
Genentech Files BPCIA Patent Infringement Suit Against Biocon Over Proposed PERJETA Biosimilar
Genentech and Hoffmann-La Roche have filed a patent infringement lawsuit against Biocon Biologics concerning a proposed biosimilar to PERJETA, a treatment for HER2-positive metastatic breast cancer. The complaint alleges infringement of 28 patents and follows the BPCIA's pre-litigation "patent dance" procedures, with both parties having agreed on the list of patents to be asserted.
United States Healthcare
GP
Goodwin Procter LLP
Article
USPTO PIER Pilot Program Targets PCT Backlog
The United States Patent and Trademark Office has launched a mandatory pilot program that fundamentally changes how certain PCT national stage applications are processed, introducing a new decision point that could significantly impact patent term adjustment and examination strategy. Selected applicants must choose between proceeding with examination, delaying for 12 months with PTA consequences, or abandoning their applications based on international phase work products.
United States IP
BT
Barnes & Thornburg LLP
See more

Highlighted Content

Latest Videos

See more